| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $173.0M | — | +19.8% |
| Cost of Revenue | $64.8M | — | -4.2% |
| Gross Profit | $108.2M | — | +40.9% |
| R&D Expense | $42.0M | — | +12.1% |
| SG&A Expense | $35.0M | — | +23.9% |
| Operating Income | -$23.9M | — | +37.4% |
| Interest Expense | $3.3M | — | +6.5% |
| Pre-tax Income | -$24.7M | — | +35.9% |
| Income Tax | -$4.1M | — | -697.7% |
| Net Income | -$20.5M | — | +47.6% |
| EPS (Basic) | -$0.13 | — | +51.9% |
| EPS (Diluted) | -$0.13 | — | +51.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $146.7M | -18.8% | +16.9% |
| Short-term Investments | $183.8M | +1.4% | +1.1% |
| Accounts Receivable | $130.0M | +10.2% | +9.2% |
| Current Assets | $490.1M | -3.3% | +8.3% |
| Total Assets | $1.51B | +0.9% | +4.4% |
| Current Liabilities | $163.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $28.9M | — | +67.0% |
| Capital Expenditures | $21.0M | — | +706.9% |
| Investing Cash Flow | -$27.0M | — | +84.9% |
| Financing Cash Flow | -$35.8M | — | -4420.4% |
| Free Cash Flow | $7.8M | — | -46.6% |
| -45.7% |
| Long-term Debt | $323.6M | +0.1% | +115.9% |
| Total Liabilities | $536.4M | -5.9% | +9.0% |
| Stockholders' Equity | $977.1M | +5.1% | +2.1% |